Posting this here because the Instagram version only has room for the headlines, and the part that matters clinically is the part that gets cut. If methyl B12 has ever made you feel worse, you have probably been given one of two pieces of advice: stop taking it, or push through. Neither is a plan. Before you do either, work out which of these three things is happening, because they need opposite responses. 1. Overmethylation Methylation is fuel on a fire. Sometimes the fire is already too hot. COMT clears your catecholamines using methyl groups. The Val158Met variant swings COMT enzyme activity by three to fourfold (Chen et al, Am J Hum Genet 2004, PMID 15457404; Tier A). Stack high-dose methylcobalamin on top of methylfolate in someone whose catecholamine turnover is already brisk and you get the picture people describe to me every week: wired, flushed, anxious, awake at 2am. This is a dose problem. The B12 is not the enemy; the quantity of methyl groups arriving at once is. Reduce the methyl donors, use niacinamide as a buffer, and reintroduce slowly. 2. Methyl trapping Folate is a key that keeps sticking in the lock. 5-MTHF can only be converted back to usable tetrahydrofolate by methionine synthase (MTR), and MTR needs active B12 to run. Without it, folate accumulates in a form the cell cannot use, homocysteine stays elevated, and adding more folate makes it worse rather than better. Scott and Weir described this in the Lancet in 1981 (PMID 6115113; Tier B). It is not new science, and it is still routinely missed. The fix here is the opposite of the first one. B12 first, then folate. 3. B12 stalling This is the one almost nobody talks about, and in my clinic it is the most common of the three among patients with mould exposure, chronic infection, heavy metal burden, or long-standing gut dysfunction. In those states, nitric oxide production runs high. NO reacts with cobalamin directly. Danishpajooh and colleagues showed spectroscopically that NO reacts with all three valency states of cobalamin and inhibits methionine synthase in living mammalian cells, disrupting carbon flow through the folate pathway (J Biol Chem 2001, PMID 11371572; Tier C, cell culture).